A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors.
about
A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase I study of BI 811283, ...... ts with advanced solid tumors.
@en
A phase I study of BI 811283, ...... ts with advanced solid tumors.
@nl
type
label
A phase I study of BI 811283, ...... ts with advanced solid tumors.
@en
A phase I study of BI 811283, ...... ts with advanced solid tumors.
@nl
prefLabel
A phase I study of BI 811283, ...... ts with advanced solid tumors.
@en
A phase I study of BI 811283, ...... ts with advanced solid tumors.
@nl
P2093
P2860
P1476
A phase I study of BI 811283, ...... ts with advanced solid tumors.
@en
P2093
Annette Frost
Bahar Nokay
Dirk Scharr
Heike Richly
James Hilbert
Klaus Mross
Max E Scheulen
Oliver Fietz
Rainer-George Goeldner
P2860
P2888
P304
P356
10.1007/S00280-016-3095-6
P577
2016-06-27T00:00:00Z